Rosiglitazone for prevention or adjuvant treatment of Nelson's syndrome after bilateral adrenalectomy

European Journal of Endocrinology

Volumn 153, Issue 4, 2005, Pages 503-505

  Andreassen, Mikkel ^a   ØStergaard Kristensen, Lars ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; ROSIGLITAZONE;

ADRENALECTOMY; ADULT; AGED; ARTICLE; CASE REPORT; CUSHING SYNDROME; DRUG DOSE REGIMEN; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERPIGMENTATION; HYPOGLYCEMIA; HYPOPHYSIS ADENOMA; MALE; NELSON SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; TRANSSPHENOIDAL SURGERY; TUMOR GROWTH;

ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; FEMALE; HUMANS; MALE; NELSON SYNDROME; THIAZOLIDINEDIONES; TIME FACTORS; TREATMENT OUTCOME;

EID: 27644599176     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01994     Document Type: Article

References (10)

1. Rees DA, Hanna FWF, Davies JS, Mils RG, Vafidis J & Scanion MF. Long-term follow-up results of Cushing's disease in a single centre using strict criteria for remission. Clinical Endocrinology 2002 56 541-551.
2. Leilani B, Mercado-Asis LB, Yanovski JA, Tracer HL, Chik CL & Cutler CB. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 514-517.
3. Pivonello R, Faggiano A, Di Salle F, Filippella M, Lombardi G & Colao A. Complete remission of Nelson's syndrome after 1-year treatment with cabergoline. Journal of Endocrinological Investigation 1999 11 860-865.
4. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 1998 47 507-514.
5. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P & Evans RM. The nuclear receptor superfamily: the second decade. Cell 1995 83 835-839.
6. Heaney AP. Novel pituitary ligands: peroxisome proliferator activating receptor-γ. Pituitary 2003 6 153-159.
7. Heaney AP, Fernando M & Melmed S. PPAR-γ receptor ligands: novel therapy for pituitary adenomas. Journal of Clinical Investigation 2003 111 1381-1388.
8. Heaney AP, Fernando M, Yong WH & Melmed S. Functional PPAR-γreceptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nature Medicine 2002 8 1281-1287.
9. Ambrosi B, Dall'Asta C, Cannavo S, Libé R, Vigo T, Epaminonda P, Chiodini I, Ferrero S, Trimarchi F, Arosio M & Beck-Peccoz P. Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease. European Journal of Endocrinology 2004 151 173-178.
10. Kelly PA, Samandouras G, Grossman AB, Afshar F, Besser GM & Jenkins PJ. Neurosurgical treatment of Nelson's syndrome. Journal of Clinical Endocrinology and Metabolism 2002 87 5465-5469.